跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALFORZIA 1 MG POLVO ORAL EN CAPSULAS PARA ABRIR - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PALFORZIA 1 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Approved
STANDARD
PALFORZIA 1 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Stallergenes
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 29, 2022
Approval ID
f1816b84dc31d65a
Company
Stallergenes
Type
Standard
Approval Details
Approval Id
f1816b84dc31d65a
Drug Cima Aemps Name
PALFORZIA 1 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Register Number
1201495002
Holder Company Name
Stallergenes
Marketing Company Name
Stallergenes
Holder Company Detail Path
/organization/stallergenes
Marketing Company Detail Path
/organization/stallergenes
Authorization Date
2022-07-29
Dosage Form
POLVO ORAL EN ENVASE UNIDOSIS
Dose
1 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Stallergenes
Company Detail Path
/organization/stallergenes
Company Information
Pharmaceutical Company Name
STALLERGENES
Country Name
France
City Name
antony,ile de france,country_fr
Address
6 RUE ALEXIS DE TOCQUEVILLE
Active Ingredients
CACAHUETE POLVO DESENGRASADO, SEMILLAS
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 29, 2022
Approval ID
f1816b84dc31d65a
Type
Standard
Back to CIMA-AEMPS Approvals
